Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Upadacitinib may effectively treat alopecia areata without side effects.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Baricitinib may effectively treat oral lichen planus.

Histone modification is key in treating chronic inflammatory skin diseases.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

The document concludes that identifying the cause of eyebrow and eyelash loss is key to treating it and improving quality of life.

Ginger extract helps hair growth and reduces the need for prednisolone in alopecia areata patients.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

Individualized treatment and psychological support are crucial for alopecia.

A teenager had both alopecia areata and vitiligo, which are rare to occur together.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

No cure exists for alopecia areata, and treatments are personalized.

The decision tree can predict drug absorption issues with good accuracy but needs more validation and adjustments for other factors.

Alopecia areata is a complex condition causing hair loss, linked to genetics and immune system issues, and may be related to other autoimmune diseases; treatments vary in effectiveness.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.